TNL Mediagene
Income Statement
| Line Item | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | $48.5M | $35.8M | $20.0M |
| Cost of Revenue | $30.8M | $23.2M | $12.3M |
| Gross Profit | $17.7M | $12.7M | $7.7M |
| Gross Margin | 36.6% | 35.3% | 38.7% |
| Operating Expenses | |||
| Research & Development | — | — | — |
| SG&A Expense | — | — | — |
| Operating Income | $-76.3M | $-7.4M | $-3.4M |
| Operating Margin | -157.4% | -20.6% | -17.1% |
| Interest Expense | $8.2M | $299.0K | — |
| Pretax Income | $-85.3M | $-1.8M | $-11.6M |
| Income Tax Expense | $-307.2K | $-591.1K | $-247.2K |
| Net Income | $-85.0M | $-805.0K | $-11.0M |
| Net Margin | -175.3% | -2.2% | -55.0% |
| EPS (Basic) | $-3.46 | $-0.04 | $-1.20 |
| EPS (Diluted) | $-3.46 | $-0.04 | $-1.20 |
| Shares Outstanding (Basic) | 26.1M | — | — |
| Shares Outstanding (Diluted) | 26.1M | — | — |
| Dividends Per Share | — | — | — |